Mark A. Robien

1.1k total citations
14 papers, 160 citations indexed

About

Mark A. Robien is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Mark A. Robien has authored 14 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Mark A. Robien's work include Renal Transplantation Outcomes and Treatments (4 papers), Transplantation: Methods and Outcomes (4 papers) and Polyomavirus and related diseases (4 papers). Mark A. Robien is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Transplantation: Methods and Outcomes (4 papers) and Polyomavirus and related diseases (4 papers). Mark A. Robien collaborates with scholars based in United States, Canada and Switzerland. Mark A. Robien's co-authors include Roslyn B. Mannon, Brian Armstrong, Aneesh K. Mehta, Yvonne Morrison, Peter G. Stock, Nancy D. Bridges, Alton B. Farris, David Iklé, Christian P. Larsen and Kenneth A. Newell and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The Journal of Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Mark A. Robien

12 papers receiving 160 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Robien United States 7 96 95 29 28 21 14 160
Ayelet Ollech Israel 7 41 0.4× 62 0.7× 32 1.1× 50 1.8× 36 1.7× 27 177
Alexandre Favà Spain 8 46 0.5× 31 0.3× 16 0.6× 27 1.0× 31 1.5× 21 131
Laura Llinàs-Mallol Spain 8 120 1.3× 75 0.8× 72 2.5× 43 1.5× 10 0.5× 15 177
Amudha Palanisamy United States 8 310 3.2× 204 2.1× 55 1.9× 37 1.3× 6 0.3× 13 351
Carmen Montoya Germany 7 30 0.3× 29 0.3× 10 0.3× 15 0.5× 12 0.6× 9 167
Piotr J. Bachul United States 10 16 0.2× 156 1.6× 5 0.2× 15 0.5× 20 1.0× 39 203
Fanni Gelley Hungary 10 48 0.5× 198 2.1× 5 0.2× 99 3.5× 7 0.3× 24 306
B. Renaud-Picard France 8 43 0.4× 126 1.3× 18 0.6× 48 1.7× 38 1.8× 30 203
A. Cochrane United States 9 77 0.8× 104 1.1× 8 0.3× 70 2.5× 16 0.8× 22 197
Pablo García Pavía Spain 5 29 0.3× 143 1.5× 7 0.2× 11 0.4× 42 2.0× 8 219

Countries citing papers authored by Mark A. Robien

Since Specialization
Citations

This map shows the geographic impact of Mark A. Robien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Robien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Robien more than expected).

Fields of papers citing papers by Mark A. Robien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Robien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Robien. The network helps show where Mark A. Robien may publish in the future.

Co-authorship network of co-authors of Mark A. Robien

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Robien. A scholar is included among the top collaborators of Mark A. Robien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Robien. Mark A. Robien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sachithanandham, Jaiprasath, John S. Lee, Janna R. Shapiro, et al.. (2025). A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching. Microbiology Spectrum. 13(3). e0219024–e0219024.
2.
Pavlisko, Elizabeth N., Megan L. Neely, Kathryn A. Wikenheiser‐Brokamp, et al.. (2024). Diagnostic alignment to optimize inter-rater reliability among lung transplant pathologists. The Journal of Heart and Lung Transplantation. 44(2). 173–181.
3.
Karaba, Andrew H., Andrew Pekosz, Christine M. Durand, et al.. (2023). Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls. The Journal of Infectious Diseases. 229(5). 1366–1371. 2 indexed citations
4.
Barton, Franca B., Thierry Berney, Jean Villard, et al.. (2023). Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation. Frontiers in Immunology. 14. 1110544–1110544. 4 indexed citations
5.
Stock, Peter G., Roslyn B. Mannon, Brian Armstrong, et al.. (2020). Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trial. American Journal of Transplantation. 20(6). 1668–1678. 18 indexed citations
6.
Shaw, Brian I., Hui‐Jie Lee, Cliburn Chan, et al.. (2020). Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantation. American Journal of Transplantation. 21(2). 766–775. 8 indexed citations
7.
Todd, Jamie L., Megan L. Neely, Heather Kopetskie, et al.. (2020). Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study. American Journal of Respiratory and Critical Care Medicine. 202(4). 576–585. 46 indexed citations
8.
Mannon, Roslyn B., Brian Armstrong, Peter G. Stock, et al.. (2020). Avoidance of CNI and steroids using belatacept—Results of the Clinical Trials in Organ Transplantation 16 trial. American Journal of Transplantation. 20(12). 3599–3608. 20 indexed citations
9.
Rozenberg, Dmitry, L.G. Singer, Megan L. Neely, et al.. (2020). Agreement between Fried Frailty Phenotype and Cumulative Deficits Frailty Indices: A Prospective Multi-Center Study. The Journal of Heart and Lung Transplantation. 39(4). S314–S314. 1 indexed citations
10.
Mehta, Sameer, Meenakshi Rana, Jennifer D. Motter, et al.. (2020). Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium. Transplantation. 105(1). 216–224. 14 indexed citations
11.
Snyder, Laurie D., Megan L. Neely, Heather Kopetskie, et al.. (2019). Improvements in Health-Related Quality of Life with Lung Transplantation: A Prospective Multicenter Cohort Study. The Journal of Heart and Lung Transplantation. 38(4). S328–S328. 1 indexed citations
12.
Martinez, Olivia M., Sheri M. Krams, Scott D. Boyd, et al.. (2018). Prospective Analysis of EBV+ PTLD in a Multi-Center Study of Pediatric Transplant Recipients. Transplantation. 102(Supplement 7). S319–S319. 1 indexed citations
13.
Newell, K.A., Aneesh K. Mehta, Christian P. Larsen, et al.. (2017). Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept. American Journal of Transplantation. 17(10). 2712–2719. 24 indexed citations
14.
Senior, Peter, Melena D. Bellin, Rodolfo Alejandro, et al.. (2015). Consistency of Quantitative Scores of Hypoglycemia Severity and Glycemic Lability and Comparison with Continuous Glucose Monitoring System Measures in Long-Standing Type 1 Diabetes. Diabetes Technology & Therapeutics. 17(4). 235–242. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026